Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Glenmark Pharmaceuticals Inc., USA recalls Propafenone Hydrochloride Extended-Release Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations
Products
  • Propafenone Hydrochloride Extended-Release Capsules
Where it was sold

U.S. Nationwide

Nationwide

Units affected
N/A
About this recall
Propafenone Hydrochloride Extended-Release Capsules, USP 325mg,60-count bottles, Rx Only, Mfd for: Northstar Rx LLC, Memphis, TN 38141, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-826-01